Nautilus Biotechnology (NAUT) Net Cash Flow (2020 - 2026)

Nautilus Biotechnology (NAUT) has 7 years of Net Cash Flow data on file, last reported at $2.2 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow fell 59.98% year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2026 stood at -$18.6 million (down 347.86% YoY), and the FY2025 full-year result was -$15.3 million, down 284.97% from the prior year.
• Net Cash Flow climbed to $2.2 million in Q1 2026, from -$11.5 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $23.2 million in Q4 2024 to a low of -$74.3 million in Q4 2022.
• A 5-year average of -$10.0 million and a median of -$844000.0 in 2024 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow plunged 1613.38% in 2024 and surged 244.43% in 2025, its largest moves.
• Tracing NAUT's Net Cash Flow over 5 years: stood at -$74.3 million in 2022, then increased by 26.37% to -$54.7 million in 2023, then soared by 142.48% to $23.2 million in 2024, then sank by 149.43% to -$11.5 million in 2025, then jumped by 119.48% to $2.2 million in 2026.
• Business Quant data shows NAUT's Net Cash Flow at $2.2 million in Q1 2026, -$11.5 million in Q4 2025, and -$10.6 million in Q3 2025.